Harpoon Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch HARP and buy or sell other stocks, ETFs, and their options commission-free!About HARP
Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. It focuses on the research of novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases.
CEODalton E. Smart, MBA, CPA
CEODalton E. Smart, MBA, CPA
Employees—
Employees—
HeadquartersRahway, New Jersey
HeadquartersRahway, New Jersey
Founded2015
Founded2015
Employees—
Employees—
HARP Key Statistics
Market cap—
Market cap—
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$23.01
52 Week high$23.01
52 Week low$23.01
52 Week low$23.01
Stock Snapshot
The current Harpoon Therapeutics(HARP) stock price is $23.01.
On 2025-12-06, Harpoon Therapeutics(HARP) stock opened at —, reached a high of —, and a low of —.
The Harpoon Therapeutics(HARP)'s current trading volume is 0.
In the last year, Harpoon Therapeutics(HARP) shares hit a 52-week high of $23.01 and a 52-week low of $23.01.
In the last year, Harpoon Therapeutics(HARP) shares hit a 52-week high of $23.01 and a 52-week low of $23.01.
People also own
Based on the portfolios of people who own HARP. This list is generated using Robinhood data, and it’s not a recommendation.